WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

Buserelin

Governed registry record

3 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. Buserelin in the treatment of prostatic cancer.

    DOI: 10.1016/0753-3322(89)90009-7

    Source identity and connection checked by Codex (AI).

  2. Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.

    DOI: 10.2165/00003495-199039030-00007PMID: 2109679

    Source identity and connection checked by Codex (AI).

  3. [Buserelin].

    DOI: 10.1055/s-0029-1235042

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Brogden RN
  • Buckley MM
  • Ward A
  • Mohr K
  • Roila F
  • Vasudevan K
  • Sztein JM